Home > Insider Trading > Filing (0001140361-13-046216)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1534275	Anthony Mauro	1500 Corporate Drive Canonsburg PA 15317	President, North America	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-11	13,089	$21.13	31,507	No	4	M	Direct
Common Stock	Disposition	2013-12-11	13,089	$42.01	18,418	No	4	S	Direct
Common Stock	Acquisiton	2013-12-11	8,698	$22.66	27,116	No	4	M	Direct
Common Stock	Disposition	2013-12-11	8,698	$41.98	18,418	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option Right to Buy	Disposition	2013-12-11	13,089	$0.00	13,089	$21.13
Common Stock	Stock Option Right to Buy	Disposition	2013-12-11	8,698	$0.00	8,698	$22.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-03-03	No	4	M	Direct
4,865		2021-03-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,574	Indirect	By 401(k) Plan

Footnotes

Represents the weighted average price of the reporting person's disposition of 13,089 shares in transactions ranging from $41.82 to $42.48.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 3 to this Form 4.
Represents the weighted average price of the reporting person's disposition of 8,698 shares in transactions ranging from $41.69 to $42.46.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 22, 2013.
The options vested in three equal installments on March 3, 2011, 2012, and 2013.
Two-thirds of the options vested in equal installments on March 2, 2012 and 2013. The remainder of the options will vest on March 2, 2014.